ARCHIVES

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

This article is from The Cancer Letter archive.

Vol. 28 No. 32 | September 6, 2002

Download PDF Visit The Full Archive

Related Articles

Techniques Developing Out Of Virus research Leading To Improved Therapy, Early Diagnosis

March 4, 1977

Reaction: Voices Of Believers Drown Out Skeptics

November 20, 2009

FDA News: Consolidation Plan Designed For Savings

June 5, 1998

New Treatment Approaches for Leukemias Emerging From Early Clinical Trials

December 31, 2004

Text of Peer Review Of Medenica’s Treatment Of Breast Cancer Patient

April 30, 1993

Protocols Approved During the Month of June 2002

July 26, 2002